NURS 615 Exam 4 2026 | Advanced Pharmacology Questions, Answers & Detailed Rationales | NP Study Guide

NURS615 x




Exam 4 2026 | Practice Questions, Answers & Detailed
x x x x x x x x




Rationales | Advanced Pharmacology Exam Prep
x x x x x x




Resource Features x




➢ NURS 615 Exam 4 practice questions
x x x x x




➢ Detailed answers x




➢ Comprehensive rationales x




➢ Pharmacology scenarios x




➢ Prescribing case studies x x

, NURS 615 Exam 4 2026 | Advanced Pharmacology
x x x x x x x




x Practice Questions, Answers & Detailed Rationales |
x x x x x x




x NP Exam Prepx x




1. Monitor Digoxin levels with:
x x x x




A. Albuterol
x




B. Theophylline
x




C. Prednisone
x




D. Montelukast
x




Answer: A x




Rationale: Albuterol and other beta-agonists can cause hypokalemia, which
x x x x x x x x




increases the risk of digoxin toxicity. When beta-agonists stimulate beta-2
x x x x x x x x x x




receptors, they promote potassium uptake into cells, lowering serum
x x x x x x x x x




potassium. Low potassium levels increase the sensitivity of cardiac muscle to
x x x x x x x x x x x




digoxin, potentially causing toxicity even at therapeutic levels. Patients
x x x x x x x x x




taking both medications should have their potassium and digoxin levels
x x x x x x x x x x




monitored.
x




2. Pheochromocytoma patients should avoid due to risk of HTN crisis:
x x x x x x x x x x




A. Beta 2 Agonists
x x x




B. Anticholinergics
x




C. Inhaled corticosteroids
x x




D. Mast cell stabilizers
x x x

,Answer: A x




Rationale: Beta-2 agonists can stimulate catecholamine release, which can
x x x x x x x x




precipitate a hypertensive crisis in patients with pheochromocytoma (a
x x x x x x x x x




catecholamine-secreting tumor). These medications increase sympathetic
x x x x x x




nervous system activity, potentially causing massive release of
x x x x x x x x




catecholamines from the tumor. Patients with known or suspected
x x x x x x x x x




pheochromocytoma should avoid beta-2 agonists and use alternative
x x x x x x x x




medications for respiratory conditions.
x x x x




3. Use with caution or avoid with African Americans:
x x x x x x x x




A. Short-acting beta agonists
x x x




B. Long-acting beta agonists
x x x




C. Inhaled corticosteroids
x x




D. Leukotriene receptor antagonists
x x x




Answer: B x




Rationale: Long-acting beta agonists (LABAs) should be used with caution
x x x x x x x x x




or avoided in African American patients due to an increased risk of severe
x x x x x x x x x x x x x




asthma exacerbations and death. Studies have shown that African American
x x x x x x x x x x




patients have a higher risk of fatal asthma events when using LABAs as
x x x x x x x x x x x x x




monotherapy. African American patients should always use LABAs in
x x x x x x x x x




combination with an inhaled corticosteroid (ICS) to reduce this risk.
x x x x x x x x x x

, 4. Black Box for long acting beta agonists:
x x x x x x x




A. Increased risk of nephrotoxicity
x x x x




B. Increased risk of death from asthma
x x x x x x




C. Increased risk of cardiac arrhythmias
x x x x x




D. Increased risk of hepatotoxicity
x x x x




Answer: B x




Rationale: Long-acting beta agonists (LABAs) carry a black box warning for
x x x x x x x x x x




an increased risk of asthma-related death. The warning is based on the
x x x x x x x x x x x x




SMART study (Salmeterol Multicenter Asthma Research Trial), which found
x x x x x x x x x




an increased risk of asthma-related mortality when LABAs were used without
x x x x x x x x x x x




concomitant inhaled corticosteroids. LABAs should only be used as add-on
x x x x x x x x x x




therapy for patients whose asthma is not controlled with ICS alone. They
x x x x x x x x x x x x




should never be used as monotherapy for asthma.
x x x x x x x x




5. Bronchodilator for patients on propranolol:
x x x x x




A. Albuterol
x




B. Ipratropium (Atrovent)
x x




C. Theophylline
x




D. Salmeterol
x




Answer: B x